Company Introduction
Founded in October 2017, X-doc.ai was initially at the forefront of enhancing Pharma R&D efficiency through cutting-edge document intelligence. Our speciality lies in managing the full scope of digital documents—including words, excel, PDFs, forms, databases, XML, and JSON—streamlining processes from authoring to knowledge extraction. While we have our roots in pharmaceuticals and a strong track record with 700+ clients in this domain, our expertise and our robust 'X-doc' core technology enable us to deliver exceptional document intelligence services across all industries, including legal.
With our global team of 200 professionals stationed in Singapore, Japan, China, and Canada, we leverage our extensive experience and versatile PaaS system to provide tailored, industry-specific documentation solutions. Our comprehensive prompt and code repository ensures we can meet the precise needs of our diverse client base, regardless of the industry.
Our Mission
Our Mission
Revolutionize the Document Value Chain with Advanced AI
Our Founders
Xing Li holds a Master’s degree in Pharmaceutics from Peking University and brings over eleven years of expertise in medical writing within the pharmaceutical industry. Her career includes roles at Pfizer, Sanofi, and Janssen, where she led the R&D medical writing and translation team.
In 2017, Xing founded X-doc.ai, leveraging her extensive experience in the pharmaceutical sector to address the complexities of technical documentation across various industries. Recognizing that pharmaceutical documentation is among the most challenging, she has applied her specialized knowledge to create AI-driven solutions that empower businesses across a multitude of sectors.
X-doc.ai utilizes large language models (LLMs) to streamline the creation and localization of intricate technical documents, aiming to make these processes virtually instantaneous. Xing's unique background in pharmaceutics and IT drives her vision of transforming documentation practices globally with cutting-edge AI solutions.
Shinya Yamamoto, Ph.D. has been contributing to the biopharmaceutical industry for 20 years + since 2003. His expertise includes technology & innovation management, digital health, clinical research & operation, regulatory and business development, etc., based on the academic backgrounds which are Chemistry (BSc), Molecular Biology (MSc) and Technology & Innovation Management (PhD).
- His professional activities are as follows:
- Specially Appointed Professor, Social Entrepreneurship Promotion Lab, Tohoku University Smart-Aging Research Center
- Guest Professor, Academic Clinical Research Center, Department of Future Medical Development, Osaka University Hospital
- Visiting Professor, Clinical Research, Innovation and Education Center, Tohoku University Hospital (CRIETO)
- Visiting Professor, Professional University of Information and Management for Innovation
- Part-Time Instructor, Global MBA Program, Hosei Business School of Innovation Management
Our Investors
